31 Oct, 2023 09:06 AM
Key Points
-- Non-renounceable entitlement offer to raise up to approximately $10 million (before direct offer costs).
-- Offer price of $0.07 per new share, a 30.0% discount to the closing pric...read more
09 Oct, 2023 10:04 AM
Sydney, Australia – 9 October 2023 – Radiopharm Theranostics (ASX:RAD), a developer of a worldclass platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is ...read more
24 Aug, 2023 09:53 AM
SYDNEY, August 24, 2023 - Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of radiopharmaceutical products for both diagnostic and therapeutic us...read more
29 May, 2023 12:33 PM
Sydney, Australia – 29 May 2023 – Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceuti...read more
17 Apr, 2023 09:43 AM
SYDNEY, 17 April 2023 - Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of radiopharmaceutical products for both diagnostic and therapeutic uses...read more
03 Mar, 2023 09:44 AM
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic us...read more
03 Mar, 2023 09:37 AM
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce...read more